New test for leprosy gives results in less than 10 minutes, New York Times reports

"A simple, fast and inexpensive new test for leprosy offers hope that, even in the poorest countries, victims can be found and cured before they become permanently disabled or disfigured like the shunned lepers of yore," the New York Times reports. "American researchers developed the test, and Brazil's drug regulatory agency registered it last month," the newspaper writes, noting, "A Brazilian diagnostics company, OrangeLife, will manufacture it on the understanding that the price will be $1 or less." According to the newspaper, "The new test gives results in under 10 minutes and is far simpler than the current diagnostic method of cutting open nodules, often in the earlobe, and looking for the bacteria under a microscope."

"A new test was crucial because trained microscope diagnosticians are rare in the rural areas where the disease persists," the New York Times notes, adding, "It is simple: one drop of blood goes into a well on a plastic test strip followed by three drops of solution." Malcolm Duthie, who led the test's development at the Infectious Disease Research Institute in Seattle, "said ... [the test] is expected to detect infections as much as a year before symptoms appear," and "the earlier treatment begins, the better the outcome" (McNeil, 2/19).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

 

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New research explores hidden health risks of hereditary hemochromatosis